

Deutsche Bank vs Manulife
Deutsche globale Bank für Firmen- und Privatkunden vs Kanadischer Versicherer und Vermögensverwalter mit Geschäft in den USA und Asien. Welche Aktie passt im September 2026 besser zu Ihrem Portfolio? Die Antwort in einfacher Sprache finden Sie unten.
Deutsche Bank spent years restructuring its investment banking operations to prove it can generate sustainable returns for European shareholders, while Manulife Financial manages insurance and wealth assets across North America and Asia with a diversified earnings engine. Both are large financial institutions navigating rate environments and capital requirements, but their business mixes and execution risks look very different. The Deutsche Bank vs Manulife comparison digs into how a restructuring investment bank compares to a diversified insurer on return on equity, capital strength, and dividend reliability.
Deutsche Bank spent years restructuring its investment banking operations to prove it can generate sustainable returns for European shareholders, while Manulife Financial manages insurance and wealth ...
Was den Kurs bewegt

Deutsche Bank stays in focus as analyst support and easing legal risk keep momentum alive
- A fresh analyst upgrade from Goldman Sachs helped fuel the move, with the firm turning more constructive on Deutsche Bank’s profitability and operating leverage, which reinforced the market’s view that earnings momentum is still improving.
- Investors also reacted to the bank’s second-quarter results, where revenue came in above expectations even though earnings per share missed, suggesting top-line strength is still outpacing near-term profit conversion.
- A recently settled Frankfurt lawsuit removed a legal overhang and was seen as limiting additional earnings drag, giving the stock another support point as traders reassessed risk.

MFC steadies after strong earnings and capital moves, even as analysts warn of deep downside
- Manulife’s recent Q2 results showed stronger-than-expected core earnings, which helped steady sentiment and kept the stock near its recent highs.
- The company also priced US$750 million of subordinated notes, a capital-raising move that strengthens its balance sheet but can make investors focus more on financing costs and future returns.
- Analyst commentary remains mixed around the stock, with some firms turning less negative while broader caution persists about valuation and the gap between current prices and bearish downside estimates.

Deutsche Bank stays in focus as analyst support and easing legal risk keep momentum alive
- A fresh analyst upgrade from Goldman Sachs helped fuel the move, with the firm turning more constructive on Deutsche Bank’s profitability and operating leverage, which reinforced the market’s view that earnings momentum is still improving.
- Investors also reacted to the bank’s second-quarter results, where revenue came in above expectations even though earnings per share missed, suggesting top-line strength is still outpacing near-term profit conversion.
- A recently settled Frankfurt lawsuit removed a legal overhang and was seen as limiting additional earnings drag, giving the stock another support point as traders reassessed risk.

MFC steadies after strong earnings and capital moves, even as analysts warn of deep downside
- Manulife’s recent Q2 results showed stronger-than-expected core earnings, which helped steady sentiment and kept the stock near its recent highs.
- The company also priced US$750 million of subordinated notes, a capital-raising move that strengthens its balance sheet but can make investors focus more on financing costs and future returns.
- Analyst commentary remains mixed around the stock, with some firms turning less negative while broader caution persists about valuation and the gap between current prices and bearish downside estimates.
Anlageanalyse
Vorteile
- Deutsche Bank benefits from a strong global presence with operations in 72 countries and leadership in key markets like Germany and Europe.
- The bank has demonstrated robust profitability, with a low price-to-earnings ratio compared to historical averages, indicating attractive valuation.
- Recent performance shows significant share price gains, supported by improved macroeconomic outlook and strategic business expansion.
Zu beachten
- Deutsche Bank faces ongoing regulatory scrutiny and legal risks, which can impact profitability and reputation.
- The company's dividend yield remains below sector average, limiting appeal for income-focused investors.
- Exposure to volatile global markets and interest rate changes increases earnings uncertainty in the near term.

Manulife
MFC
Vorteile
- Manulife Financial has a large market capitalisation and a diversified global footprint, strengthening its competitive position in insurance and asset management.
- The company has delivered positive long-term performance, with solid returns over the past year despite sector headwinds.
- Manulife maintains a resilient balance sheet, supporting its ability to weather economic downturns and regulatory changes.
Zu beachten
- Manulife's share price has underperformed its 52-week high, reflecting investor caution amid broader market volatility.
- The business is sensitive to interest rate fluctuations, which can affect investment returns and profitability.
- Growth in core markets has slowed, with limited near-term catalysts for significant revenue acceleration.
Deutsche Bank (DB) – Nächster Termin für Quartalszahlen
The next earnings date for DB is October 28, 2026. It is expected to cover Q3 2026 results. This timing matches Deutsche Bank’s established quarterly reporting pattern.
Manulife (MFC) – Nächster Termin für Quartalszahlen
The next expected earnings date for MFC is November 4, 2026, based on the company’s typical reporting pattern. This release would cover Q3 2026 results. If the date shifts, the earnings call has generally followed shortly afterward.
Deutsche Bank (DB) – Nächster Termin für Quartalszahlen
The next earnings date for DB is October 28, 2026. It is expected to cover Q3 2026 results. This timing matches Deutsche Bank’s established quarterly reporting pattern.
Manulife (MFC) – Nächster Termin für Quartalszahlen
The next expected earnings date for MFC is November 4, 2026, based on the company’s typical reporting pattern. This release would cover Q3 2026 results. If the date shifts, the earnings call has generally followed shortly afterward.
DB oder MFC in Nemo kaufen
Ohne Provision
Handeln Sie Aktien, ETFs und mehr ohne Provision. Behalten Sie mehr von Ihrer Rendite.
Vertrauenswürdig & reguliert
Seit 2015 Teil der Exinity Group, mit über einer Million Kunden weltweit.
6 % Zinsen auf Guthaben
Erhalten Sie 6 % Zinsen p.a. auf nicht investiertes Guthaben, mit täglicher Zinsgutschrift.


